The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory bowel disease

Frontiers in Microbiology

Volumn 9, Issue SEP, 2018, Pages

  Zuo, Tao ^a,b   Ng, Siew C ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Bacteria; Diet; Fecal microbiota transplantation; Gut microbiota; Helminths; Inflammatory bowel disease; Mycobiota; Virobiota

Indexed keywords

ANTIBIOTIC AGENT; CD36 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PREBIOTIC AGENT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7;

ANAEROBIC BACTERIUM; ASCOMYCETES; BACTERIAL FLORA; BASIDIOMYCETES; CANDIDA ALBICANS; CAUDOVIRALES; CLOSTRIDIUM DIFFICILE INFECTION; DIET; DYSBIOSIS; ENTERITIS; ENTEROBACTERIACEAE; ESCHERICHIA; FECAL MICROBIOTA TRANSPLANTATION; GAMMAPROTEOBACTERIA; GENE EXPRESSION; GENE MUTATION; HELMINTH; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIAL COLONIZATION; MYCOBIOTA; NONHUMAN; PATHOGENESIS; REVIEW; SHIGELLA; THERAPY EFFECT; VIROBIOTA;

EID: 85055312289     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2018.02247     Document Type: Review

References (184)

1. Agus, A., Denizot, J., Thevenot, J., Martinez-Medina, M., Massier, S., Sauvanet, P., et al. (2016). Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive, E. coli infection and intestinal inflammation. Sci. Rep. 6:19032. doi:10.1038/srep19032.
2. Ahmad, M. S., Krishnan, S., Ramakrishna, B. S., Mathan, M., Pulimood, A. B., and Murthy, S. N. (2000). Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 46, 493-499. doi:10.1136/gut.46.4.493.
3. Albenberg, L. G., and Wu, G. D. (2014). Diet and the intestinal microbiome: Associations, functions, and implications for health and disease. Gastroenterology 146, 1564-1572. doi:10.1053/j.gastro.2014.01.058.
4. Angelberger, S., Reinisch, W., Makristathis, A., Lichtenberger, C., Dejaco, C., Papay, P., et al. (2013). Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am. J. Gastroenterol. 108, 1620-1630. doi:10.1038/ajg.2013.257.
5. Arnold, I. C., Lee, J. Y., Amieva, M. R., Roers, A., Flavell, R. A., Sparwasser, T., et al. (2011). Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 140, 199-209. doi:10.1053/j.gastro.2010.06.047.
6. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., et al. (2013). T-reg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236. doi:10.1038/nature12331.
7. Bäckhed, F., Fraser, C. M., Ringel, Y., Sanders, M. E., Sartor, R. B., Sherman, P. M., et al. (2012). Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12, 611-622. doi:10.1016/j.chom.2012.10.012.
8. Backhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., et al. (2015). Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:852. doi:10.1016/j.chom.2015.05.012.
9. Barr, J., Auro, R., Furlan, M., Whiteson, K., Talago, N., Paul, L., et al. (2013). Bacteriophage adhered to mucus provide a novel mucosal immune system. J. Immunol. 190:61.8.
10. Barr, J. J., Auro, R., Furlan, M., Whiteson, K. L., Erb, M. L., Pogliano, J., et al. (2013). Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl. Acad. Sci. U.S.A. 110, 10771-10776. doi:10.1073/pnas.1305923110.
11. Barreiro-de Acosta, M., Alvarez Castro, A., Souto, R., Iglesias, M., Lorenzo, A., and Dominguez-Munoz, J. E. (2011). Emigration to western industrialized countries: A risk factor for developing inflammatory bowel disease. J. Crohns Colitis 5, 566-569. doi:10.1016/j.crohns, .2011.05.009.
12. Benchimol, E. I., Guttmann, A., Griffiths, A. M., Rabeneck, L., Mack, D. R., Brill, H., et al. (2009). Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: Evidence from health administrative data. Gut 58, 1490-1497. doi:10.1136/gut.2009.188383.
13. Benchimol, E. I., Kaplan, G. G., Otley, A. R., Nguyen, G. C., Underwood, F. E., Guttmann, A., et al. (2017). Rural and urban residence during early life is associated with a lower risk of inflammatory bowel disease: A population-based inception and birth cohort study. Am. J. Gastroenterol. 112, 1412-1422. doi:10.1038/ajg.2017.208.
14. Benchimol, E. I., Manuel, D. G., Guttmann, A., Nguyen, G. C., Mojaverian, N., Quach, P., et al. (2014). Changing age demographics of inflammatory bowel disease in ontario, canada: A population-based cohort study of epidemiology trends. Inflamm. Bowel Dis. 20, 1761-1769. doi:10.1097/MIB.0000000000000103.
15. Benjamin, J. L., Hedin, C. R., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Prescott, N. J., et al. (2012). Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm. Bowel Dis. 18, 1092-1100. doi:10.1002/ibd.21864.
16. Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., et al. (2005). VSL# 3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100, 1539-1546. doi:10.1111/j.1572-0241.2005.41794.x.
17. Borody, T. J., Warren, E. F., Leis, S., Surace, R., and Ashman, O. (2003). Treatment of ulcerative colitis using fecal bacteriotherapy. J. Clin. Gastroenterol. 37, 42-47. doi:10.1097/00004836-200307000-00012.
18. Brito, I. L., and Alm, E. J. (2016). Tracking strains in the microbiome: insights from metagenomics and models. Front. Microbiol. 7:712. doi:10.3389/fmicb.2016.00712.
19. Broadhurst, M. J., Leung, J. M., Kashyap, V., McCune, J. M., Mahadevan, U., McKerrow, J. H., et al. (2010). IL-22(+) CD4(+) T Cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci. Transl. Med. 2:60-88. doi:10.1126/scitranslmed.3001500.
20. Brun, P., Castagliuolo, I., Di Leo, V., Buda, A., Pinzani, M., Palù, G., et al. (2007). Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastr. L 292, G518-G525. doi:10.1152/ajpgi.00024.2006.
21. Brüssow, H., Canchaya, C., and Hardt, W. D. (2004). Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion. Microbiol. Mol. Biol. R 68, 560-602. doi:10.1128/MMBR.68.3.560-602.2004.
22. Cadwell, K., Patel, K. K., Maloney, N. S., Liu, T. C., Ng, A. C., Storer, C. E., et al. (2010). Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145. doi:10.1016/j.cell.2010.05.009.
23. Callaway, T. R., Edrington, T. S., Anderson, R. C., Harvey, R. B., Genovese, K. J., Kennedy, C. N., et al. (2008). Probiotics, prebiotics and competitive exclusion for prophylaxis against bacterial disease. Anim. Health Res. Rev. 9, 217-225. doi:10.1017/S1466252308001540.
24. Carrillo-Larco, R. M., Bernabé-Ortiz, A., Pillay, T. D., Gilman, R. H., Sanchez, J. F., Poterico, J. A., et al. (2016). Obesity risk in rural, urban and rural-To-urban migrants: prospective results of the PERU MIGRANT study. Int. J. Obes. 40, 181-185. doi:10.1038/ijo.2015.140.
25. Casen, C., Vebo, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., et al. (2015). Deviations in human gut microbiota: A novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment. Pharmacol. Ther. 42, 71-83. doi:10.1111/apt.13236.
26. Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., et al. (2012). Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306. doi:10.1101/gr.126516.111.
27. Chassaing, B., and Darfeuille-Michaud, A. (2011). The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1720-1728. doi:10.1053/j.gastro.2011.01.054.
28. Scholar Chassaing, B., Tran, H., and Gewirtz, A. (2016). O-007 Colitis vaccine: flagellin-elicited immunity keeps motile bacteria in check and protects against intestinal inflammation. Inflamm. Bowel Dis. 22: 3. doi:10.1097/01.MIB.0000480045.11503.c5.
29. Chehoud, C., Dryga, A., Hwang, Y., Nagy-Szakal, D., Hollister, E. B., Luna, R. A., et al. (2016). Transfer of viral communities between human individuals during fecal microbiota transplantation. mBio 7: 0322. doi:10.1128/mBio.00322-16.
30. Chiba, M., Tsuji, T., Nakane, K., and Komatsu, M. (2015). High amount of dietary fiber not harmful but favorable for Crohn disease. Perm. J. 19, 58-91. doi:10.7812/TPP/14-124.
31. Colman, R. J., and Rubin, D. T. (2014). Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-Analysis. J. Crohns Colitis 8, 1569-1581. doi:10.1016/j.crohns.2014.08.006.
32. Conlon, M. A., and Bird, A. R. (2015). The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7, 17-44. doi:10.3390/nu7010017.
33. Costello, S., Waters, O., Bryant, R., Katsikeros, R., Makanyanga, J., Schoeman, M., et al. (2017). Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: A randomised controlled trial. J. Crohns Colitis 11, 23. doi:10.1093/ecco-jcc/jjx002.035.
34. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A. L., Barnich, N., et al. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421. doi:10.1053/j.gastro.2004.04.061.
35. Dave, M., Higgins, P. D., Middha, S., and Rioux, K. P. (2012). The human gut microbiome: current knowledge, challenges, and future directions. Transl. Res. 160, 246-257. doi:10.1016/j.trsl.2012.05.003.
36. David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563. doi:10.1038/nature12820.
37. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., et al. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A. 107, 14691-14696. doi:10.1073/pnas.1005963107.
38. De Leon, L. M., Watson, J. B., and Kelly, C. R. (2013). Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent clostridium difficile infection. Clin. Gastroenterol. Hepatol. 11, 1036-1038. doi:10.1016/j.cgh.2013.04.045.
39. Desai, M. S., Seekatz, A. M., Koropatkin, N. M., Kamada, N., Hickey, C. A., Wolter, M., et al. (2016). A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339-1353. 21. doi:10.1016/j.cell.2016.10.043.
40. Dethlefsen, L., and Relman, D. A. (2011). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U.S.A. 108, 4554-4561. doi:10.1073/pnas.1000087107.
41. Dicksved, J., Halfvarson, J., Rosenquist, M., Järnerot, G., Tysk, C., Apajalahti, J., et al. (2008). Molecular analysis of the gut microbiota of identical twins with Crohn's disease. Isme J. 2, 716-727. doi:10.1038/ismej.2008.37.
42. Dollive, S., Chen, Y. Y., Grunberg, S., Bittinger, K., Hoffmann, C., Vandivier, L., et al. (2013). Fungi of the murine gut: Episodic variation and proliferation during antibiotic treatment. PLoS ONE 8:71806. doi:10.1371/journal.pone.0071806.
43. El Kaoutari, A., Armougom, F., Gordon, J. I., Raoult, D., and Henrissat, B. (2013). The abundance and variety of carbohydrate-Active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11, 497-504. doi:10.1038/nrmicro3050.
44. Elliott, D. E., Metwali, A., Leung, J., Setiawan, T., Blum, A. M., Ince, M. N., et al. (2008). Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J. Immunol. 181, 2414-2419. doi:10.4049/jimmunol.181.4.2414.
45. Elliott, D. E., and Weinstock, J. V. (2012). Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann. N. Y. Acad. Sci. 1247, 83-96. doi:10.1111/j.1749-6632.2011.06292.x.
46. Frank, D. N., Robertson, C. E., Hamm, C. M., Kpadeh, Z., Zhang, T., Chen, H., et al. (2011). Disease phenotype and genotype are associated with shifts in intestinal-Associated microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 17, 179-184. doi:10.1002/ibd.21339.
47. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785. doi:10.1073/pnas.0706625104.
48. Galvez, J., Rodríguez-Cabezas, M. E., and Zarzuelo, A. (2005). Effects of dietary fiber on inflammatory bowel disease. Mol. Nutr. Food Res. 49, 601-608. doi:10.1002/mnfr.200500013.
49. Gensollen, T., Iyer, S. S., Kasper, D. L., and Blumberg, R. S. (2016). How colonization by microbiota in early life shapes the immune system. Science 352, 539-544. doi:10.1126/science.aad9378.
50. Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., et al. (2014). The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392. doi:10.1016/j.chom.2014.02.005.
51. Górski, A., Wazna, E., Dabrowska, B. W., Dabrowska, K., Switala-Jelen, K., and Miedzybrodzki, R. (2006). Bacteriophage translocation. FEMS Immunol. Med. Mic. 46, 313-319. doi:10.1111/j.1574-695X.2006.00044.x.
52. Griffin, N. W., Ahern, P. P., Cheng, J., Heath, A. C., Ilkayeva, O., Newgard, C. B., et al. (2017). Prior dietary practices and connections to a human gut microbial metacommunity alter responses to diet interventions. Cell Host Microbe 21, 84-96. doi:10.1016/j.chom.2016.12.006.
53. Haberman, Y., Tickle, T. L., Dexheimer, P. J., Kim, M. O., Tang, D., Karns, R., et al. (2014). Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J. Clin. Invest. 124, 3617-3633. doi:10.1172/JCI75436.
54. Halfvarson, J., Brislawn, C. J., Lamendella, R., Vázquez-Baeza, Y., Walters, W. A., Bramer, L. M., et al. (2017). Dynamics of the human gut microbiome in inflammatory bowel disease. Nat. Microbiol. 2:17004 doi:10.1038/nmicrobiol.2017.4.
55. Hammer, T., Nielsen, K. R., Munkholm, P., Burisch, J., and Lynge, E. (2016). The faroese IBD study: incidence of inflammatory bowel diseases across 54 years of population-based data. J. Crohns Colitis 10, 934-942. doi:10.1093/ecco-jcc/jjw050.
56. Hang, L., Blum, A. M., Setiawan, T., Urban, J. P., Stoyanoff, K. M., and Weinstock, J. V. (2013). Heligmosomoides polygyrus bakeri infection activates colonic Foxp3(+) T cells enhancing their capacity to prevent colitis. J. Immunol. 191, 1927-1934. doi:10.4049/jimmunol.1201457.
57. Hansen, R., Mukhopadhya, I., Meharg, C., Russell, R., Berry, S., El-Omar, E., et al. (2013). The role of the fungal microbiota in the pathogenesis of de-novo paediatric inflammatory bowel disease using next generation sequencing. Gut 62, 32. doi:10.1136/gutjnl-2013-304907.073.
58. Harnett, W., and Harnett, M. M. (2006). Filarial nematode secreted product ES-62 is an anti-inflammatory agent: Therapeutic potential of small molecule derivatives and ES-62 peptide mimetics. Clin. Exp. Pharmacol. Physiol. 33, 511-518. doi:10.1111/j.1440-1681.2006.04400.x.
59. Helmby, H. (2015). Human helminth therapy to treat inflammatory disorders- where do we stand? BMC Immunol. 16:12. doi:10.1186/s12865-015-0074-3.
60. Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H. Z., Wu, G. D., et al. (2013). Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE 8: 66019. doi:10.1371/journal.pone.0066019.
61. Huffnagle, G. B., and Noverr, M. C. (2013). The emerging world of the fungal microbiome. Trends Microbiol. 21, 334-341. doi:10.1016/j.tim.2013.04.002.
62. Iliev, I. D., Funari, V. A., Taylor, K. D., Nguyen, Q., Reyes, C. N., Strom, S. P., et al. (2012). Interactions between commensal fungi and the C-Type lectin receptor dectin-1 influence colitis. Science 336, 1314-1317. doi:10.1126/science.1221789.
63. Jandhyala, S. M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M., and Nageshwar Reddy, D. (2015). Role of the normal gut microbiota. World J. Gastroenterol. 21, 8787-8803. doi:10.3748/wjg.v21.i29.8787.
64. Kamada, N., Chen, G., and Núñez, G. (2012). A complex microworld in the gut: harnessing pathogen-commensal relations. Nat. Med. 18, 1190-1191. doi:10.1038/nm.2900.
65. Kang, S., Denman, S. E., Morrison, M., Yu, Z., Dore, J., Leclerc, M., et al. (2010). Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel Dis. 16, 2034-2042. doi:10.1002/ibd.21319.
66. Kaplan, G. G. (2015). The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastro. Hepat. 12, 720-727. doi:10.1038/nrgastro.2015.150.
67. Kassam, Z., Lee, C. H., Yuan, Y., and Hunt, R. H. (2013). Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-Analysis. Am. J. Gastroenterol. 108, 500-508. doi:10.1038/ajg.2013.59.
68. Kelly, C. R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A., et al. (2014b). Fecal microbiota transplant for treatment of clostridium difficile infection in immunocompromised patients. Am. J. Gastroenterol. 109, 1065-1071. doi:10.1038/ajg.2014.133.
69. Kelly, C. R., Kahn, S. A., and Kashyap, P. (2015). Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook (vol 149, pg 223, 2015). Gastroenterology 149, 1644-1644. doi:10.1053/j.gastro.2015.05.008.
70. Kelly, C. R., Ziud, H., and Kahn, S. (2014a). New diagnosis of Crohn's colits 6 weeks after fecal microbiota transplantation. Inflamm. Bowel Dis. 20: 21. doi:10.1097/01.MIB.0000456762.32133.2e.
71. Kelly, D., Campbell, J. I., King, T. P., Grant, G., Jansson, E. A., Coutts, A. G., et al. (2004). Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-[gamma] and RelA. Nat. Immunol. 5, 104-112. doi:10.1038/ni1018.
72. Kernbauer, E., Ding, Y., and Cadwell, K. (2014). An enteric virus can replace the beneficial function of commensal bacteria. Nature 516, 94-98. doi:10.1038/nature13960.
73. Khoruts, A., and Sadowsky, M. J. (2016). Understanding the mechanisms of faecal microbiota transplantation. Nat. Rev. Gastro. Hepat. 13, 508-516. doi:10.1038/nrgastro.2016.98.
74. Kim, M. S., and Bae, J. W. (2016). Spatial disturbances in altered mucosal and luminal gut viromes of diet-induced obese mice. Environ. Microbiol. 18, 1498-1510. doi:10.1111/1462-2920.13182.
75. Kitajima, S., Morimoto, M., Sagara, E., Shimizu, C., and Ikeda, Y. (2001). Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp. Anim. Tokyo 50, 387-395. doi:10.1538/expanim.50.387.
76. Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., et al. (2011). Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 108, 4578-4585. doi:10.1073/pnas.1000081107.
77. Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., et al. (2013). Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215. doi:10.1016/j.chom.2013.07.007.
78. Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., et al. (2012). Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298. doi:10.1101/gr.126573.111.
79. Lecuit, M., and Eloit, M. (2013). The human virome: new tools and concepts. Trends Microbiol. 21, 510-515. doi:10.1016/j.tim.2013.07.001.
80. Lee, S. C., Tang, M. S., Lim, Y. A., Choy, S. H., Kurtz, Z. D., Cox, L. M., et al. (2014). Helminth colonization is associated with increased diversity of the gut microbiota. PLoS Negl. Trop. Dis. 8: 2880. doi:10.1371/journal.pntd.0002880.
81. Lepage, P., Colombet, J., Marteau, P., Sime-Ngando, T., Doré, J., and Leclerc, M. (2008). Dysbiosis in inflammatory bowel disease: A role for bacteriophages? Gut 57, 424-425. doi:10.1136/gut.2007.134668.
82. Levitz, S. M. (2010). Innate recognition of fungal cell walls. PLoS Pathog. 6:1000758. doi:10.1371/journal.ppat.1000758.
83. Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., et al. (2008). Evolution of mammals and their gut microbes. Science 320, 1647-1651. doi:10.1126/science.1155725.
84. Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848. doi:10.1016/j.cell.2006.02.017.
85. Li, S. S., Zhu, A., Benes, V., Costea, P. I., Hercog, R., Hildebrand, F., et al. (2016). Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352, 586-589. doi:10.1126/science.aad8852.
86. Liguori, G., Lamas, B., Richard, M. L., Brandi, G., da Costa, G., Hoffmann, T. W., et al. (2016). Fungal dysbiosis in mucosa-Associated microbiota of Crohn's disease patients. J. Crohns Colitis 10, 296-305. doi:10.1093/ecco-jcc/jjv209.
87. Llopis, M., Antolin, M., Carol, M., Borruel, N., Casellas, F., Martinez, C., et al. (2009). Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa. Inflamm. Bowel Dis. 15, 275-283. doi:10.1002/ibd.20736.
88. Lupp, C., Robertson, M. L., Wickham, M. E., Sekirov, I., Champion, O. L., Gaynor, E. C., et al. (2007). Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119-129. doi:10.1016/j.chom.2007.06.010.
89. Machiels, K., Sabino, J., Vandermosten, L., Joossens, M., Arijs, I., de Bruyn, M., et al. (2017). Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut 66, 79-88. doi:10.1136/gutjnl-2015-309398.
90. Maharshak, N., Huh, E. Y., Paiboonrungruang, C., Shanahan, M., Thurlow, L., Herzog, J., et al. (2015). Enterococcus faecalis gelatinase mediates intestinal permeability via protease-Activated receptor 2. Infect. Immun. 83, 2762-2770. doi:10.1128/IAI.00425-15.
91. Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., et al. (2018). Extensive impact of non-Antibiotic drugs on human gut bacteria. Nature 555, 623-628. doi:10.1038/nature25979.
92. Maiques, E., Ubeda, C., Campoy, S., Salvador, N., Lasa, I., Novick, R. P., et al. (2006). Beta-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus. J. Bacteriol. 188, 2726-2729. doi:10.1128/JB.188.7.2726-2729.2006.
93. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211. doi:10.1136/gut.2005.073817.
94. Martinez, C., Antolin, M., Santos, J., Torrejon, A., Casellas, F., Borruel, N., et al. (2008). Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am. J. Gastroenterol. 103, 643-648. doi:10.1111/j.1572-0241.2007.01592.x.
95. Martínez, I., Stegen, J. C., Maldonado-Gomez, M. X., Eren, A. M., Siba, P. M., Greenhill, A. R., et al. (2015). The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes. Cell Rep. 11, 527-538. doi:10.1016/j.celrep.2015.03.049.
96. Maslowski, K. M., and Mackay, C. R. (2011). Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5-9. doi:10.1038/ni0111-5.
97. Mckenzie, H., Main, J., Pennington, C. R., and Parratt, D. (1990). Antibody to selected strains of saccharomyces-cerevisiae (Bakers and Brewers-Yeast) and Candida-Albicans in Crohns-disease. Gut 31, 536-538. doi:10.1136/gut.31.5.536.
98. Medellin-Pena, M. J., Wang, H. F., Johnson, R., Anand, S., and Griffiths, M. W. (2007). Probiotics affect virulence-related gene expression in Escherichia coli O157: H7. Appl. Environ. Microb. 73, 4259-4267. doi:10.1128/AEM.00159-07.
99. Minot, S., Bryson, A., Chehoud, C., Wu, G. D., Lewis, J. D., and Bushman, F. D. (2013). Rapid evolution of the human gut virome. Proc. Natl. Acad. Sci. U.S.A. 110, 12450-12455. doi:10.1073/pnas.1300833110.
100. Minot, S., Grunberg, S., Wu, G. D., Lewis, J. D., and Bushman, F. D. (2012). Hypervariable loci in the human gut virome. Proc. Natl. Acad. Sci. U.S.A. 109, 3962-3966. doi:10.1073/pnas.1119061109.
101. Minot, S., Sinha, R., Chen, J., Li, H. Z., Keilbaugh, S. A., Wu, G. D., et al. (2011). The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21, 1616-1625. doi:10.1101/gr.122705.111.
102. Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., et al. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54. doi:10.1053/j.gastro.2011.10.001.
103. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13: 79. doi:10.1186/gb-2012-13-9-r79.
104. Motomura, Y., Wang, H., Deng, Y., El-Sharkawy, R. T., Verdu, E. F., and Khan, W. I. (2009). Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin. Exp. Immunol. 155, 88-95. doi:10.1111/j.1365-2249.2008.03805.x.
105. Muegge, B. D., Kuczynski, J., Knights, D., Clemente, J. C., González, A., Fontana, L., et al. (2011). Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332, 970-974. doi:10.1126/science.1198719.
106. Mukhopadhya, I., Hansen, R., Meharg, C., Thomson, J. M., Russell, R. K., Berry, S. H., et al. (2015). The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect. 17, 304-310. doi:10.1016/j.micinf.2014.12.001.
107. Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., et al. (2015). Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447-460. doi:10.1016/j.cell.2015.01.002.
108. Noverr, M. C., Noggle, R. M., Toews, G. B., and Huffnagle, G. B. (2004). Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72, 4996-5003. doi:10.1128/IAI.72.9.4996-5003.2004.
109. Obregon-Tito, A. J., Tito, R. Y., Metcalf, J., Sankaranarayanan, K., Clemente, J. C., Ursell, L. K., et al. (2015). Subsistence strategies in traditional societies distinguish gut microbiomes. Nat. Commun. 6:6505. doi:10.1038/ncomms7505.
110. Oertli, M., and Müller, A. (2012). Helicobacter pylori targets dendritic cells to induce immune tolerance, promote persistence and confer protection against allergic asthma. Gut Microbes 3, 566-571. doi:10.4161/gmic.21750.
111. Oertli, M., Sundquist, M., Hitzler, I., Engler, D. B., Arnold, I. C., Reuter, S., et al. (2012). DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J. Clin. Invest. 122, 1082-1096. doi:10.1172/JCI61029.
112. Ogilvie, L. A., and Jones, B. V. (2015). The human gut virome: A multifaceted majority. Front. Microbiol. 6:918. doi:10.3389/fmicb.2015.00918.
113. O'Hara, A. M., and Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Rep. 7, 688-693. doi:10.1038/sj.embor.7400731.
114. Ohkusa, T., Kato, K., Terao, S., Chiba, T., Mabe, K., Murakami, K. et al. (2010). Newly developed antibiotic combination therapy for ulcerative colitis: A double-blind placebo-controlled multicenter trial. Am. J. Gastroenterol. 105, 1820-1829. doi:10.1038/ajg.2010.84.
115. Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., and Sato, N. (2003). Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52, 79-83. doi:10.1136/gut.52.1.79.
116. Ohkusa, T., Sato, N., Ogihara, T., Morita, K., Ogawa, M., and Okayasu, I. (2002). Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J. Gastroenterol. Hepatol. 17, 849-853. doi:10.1046/j.1440-1746.2002.02834.x.
117. Ohkusa, T., Yoshida, T., Sato, N., Watanabe, S., Tajiri, H., and Okayasu, I. (2009). Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: A possible pathogenic mechanism of ulcerative colitis. J. Med. Microbiol. 58, 535-545. doi:10.1099/jmm.0.005801-0.
118. Ott, S. J., Kuhbacher, T., Musfeldt, M., Rosenstiel, P., Hellmig, S., Rehman, A., et al. (2008). Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastroentero. 43, 831-841. doi:10.1080/00365520801935434.
119. Papamichael, K., Konstantopoulos, P., and Mantzaris, G. J. (2014). Helicobacter pylori infection and inflammatory bowel disease: is there a link? World J. Gastroenterol. 20:6374. doi:10.3748/wjg.v20.i21.6374.
120. Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., et al. (2017). Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial. Lancet 389, 1218-1228. doi:10.1016/S0140-6736(17)30182-4.
121. Parent, K., and Wilson, I. D. (1971). Mycobacteriophage in Crohn's disease. Gut 12, 1019-1020. doi:10.1136/gut.12.12.1019.
122. Patwa, L. G., Fan, T. J., Tchaptchet, S., Liu, Y., Lussier, Y. A., Sartor, R. B., et al. (2011). Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 141, 1842-1851. 1-10. doi:10.1053/j.gastro, .2011.06.064.
123. Perez-Brocal, V., Garcia-Lopez, R., Vazquez-Castellanos, J. F., Nos, P., Beltran, B., Latorre, A., et al. (2013). Study of the viral and microbial communities associated with Crohn's disease: A metagenomic approach. Clin. Transl. Gastroen. 4: 36. doi:10.1038/ctg.2013.9.
124. Pituch-Zdanowska, A., Banaszkiewicz, A., and Albrecht, P. (2015). The role of dietary fibre in inflammatory bowel disease. Prz. Gastroenterol. 10, 135-141. doi:10.5114/pg.2015.52753.
125. Probert, C. S., Jayanthi, V., Pinder, D., Wicks, A. C., and Mayberry, J. F. (1992). Epidemiologic-study of ulcerative proctocolitis in indian migrants and the indigenous population of leicestershire. Gut 33, 687-693. doi:10.1136/gut.33.5.687.
126. Putignani, L., Del Chierico, F., Vernocchi, P., Cicala, M., Cucchiara, S., Dallapiccola, B., et al. (2016). Gut microbiota dysbiosis as risk and premorbid factors of IBD and IBS along the childhood-Adulthood transition. Inflamm. Bowel Dis. 22, 487-504. doi:10.1097/MIB.0000000000000602.
127. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalog established by metagenomic sequencing. Nature 464, 59-65. doi:10.1038/nature08821.
128. Rajca, S., Grondin, V., Louis, E., Vernier-Massouille, G., Grimaud, J. C., Bouhnik, Y., et al. (2014). Alterations in the intestinal microbiome (Dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm. Bowel Dis. 20, 978-986. doi:10.1097/MIB.0000000000000036.
129. Ramanan, D., Bowcutt, R., Lee, S. C., Tang, M. S., Kurtz, Z. D., Ding, Y., et al. (2016). Helminth infection promotes colonization resistance via type 2 immunity. Science 352, 608-612. doi:10.1126/science.aaf3229.
130. Reyes, A., Haynes, M., Hanson, N., Angly, F. E., Heath, A. C., Rohwer, F., et al. (2010). Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466, 334-338. doi:10.1038/nature09199.
131. Reyes, A., Wu, M., McNulty, N. P., Rohwer, F. L., and Gordon, J. I. (2013). Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut. Proc. Natl. Acad. Sci. U.S.A. 110, 20236-20241. doi:10.1073/pnas.1319470110.
132. Rocchi, A., Benchimol, E. I., Bernstein, C. N., Bitton, A., Feagan, B., Panaccione, R., et al. (2012). Inflammatory bowel disease: A Canadian burden of illness review. Can J. Gastroenterol. 26, 811-817. doi:10.1155/2012/984575.
133. Rokkas, T., Gisbert, J. P., Niv, Y., and O'morain, C. (2015). The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-Analysis. United Eur Gastroenterol. J. 3, 539-550. doi:10.1177/2050640615580889.
134. Round, J. L., Lee, S. M., Li, J., Tran, G., Jabri, B., Chatila, T. A., et al. (2011). The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977. doi:10.1126/science.1206095.
135. Round, J. L., and Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323. doi:10.1038/nri2515.
136. Ruyssers, N. E., De Winter, B. Y., De Man, J. G., Loukas, A., Pearson, M. S., Weinstock, J. V., et al. (2009). Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm. Bowel Dis. 15, 491-500. doi:10.1002/ibd.20787.
137. Sartor, R. B. (2008). Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577-594. doi:10.1053/j.gastro.2007.11.059.
138. Sartor, R. B., and Wu, G. D. (2017). Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 152, 327-339. doi:10.1053/j.gastro.2016.10.012.
139. Schnorr, S. L., Candela, M., Rampelli, S., Centanni, M., Consolandi, C., Basaglia, G., et al. (2014). Gut microbiome of the Hadza hunter-gatherers. Nat. Commun. 5:3654 doi:10.1038/ncomms4654.
140. Schultz, M. (2008). Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm. Bowel Dis. 14, 1012-1018. doi:10.1002/ibd.20377.
141. Schwiertz, A., Jacobi, M., Frick, J., Markus, R., Rusch, K., and Kohler, H. (2010). Microbiota in pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutri. 50, E105-E105. doi:10.1016/j.jpeds.2010.02.046.
142. Sepehri, S., Kotlowski, R., Bernstein, C. N., and Krause, D. O. (2007). Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm. Bowel Dis. 13, 675-683. doi:10.1002/ibd.20101.
143. Shaw, K. A., Bertha, M., Hofmekler, T., Chopra, P., Vatanen, T., Srivatsa, A., et al. (2016). Dysbiosis, inflammation, and response to treatment: A longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med. 8:75. doi:10.1186/s13073-016-0331-y.
144. Shivashankar, R., Beauvais, J. C., and Lewis, J. D. (2017). The relationship of regional diets with global incidence rates of inflammatory bowel disease. Gastroenterology 152, S975-S976. doi:10.1016/S0016-5085(17)33306-1.
145. Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C., Bohlooly-y, M., et al. (2013). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573. doi:10.1126/science.1241165.
146. Sokol, H., Leducq, V., Aschard, H., Pham, H. P., Jegou, S., Landman, C., et al. (2017). Fungal microbiota dysbiosis in IBD. Gut 66, 1039-1048. doi:10.1136/gutjnl-2015-310746.
147. Sokol, H., Lepage, P., Seksik, P., Dore, J., and Marteau, P. (2006). Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J. Clin. Microbiol. 44, 3172-3177. doi:10.1128/JCM.02600-05.
148. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L. G., Gratadoux, J. J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105, 16731-16736. doi:10.1073/pnas.0804812105.
149. Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., et al. (2009). Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183-1189. doi:10.1002/ibd.20903.
150. Soll, D. R., Galask, R., Schmid, J., Hanna, C., Mac, K., and Morrow, B. (1991). Genetic dissimilarity of commensal strains of candida spp carried in different anatomical locations of the same healthy women. J. Clin. Microbiol. 29, 1702-1710.
151. Soon, S., Molodecky, N. A., Rabi, D. M., Ghali, W. A., Barkema, H. W., and Kaplan, G. G. (2012). The relationship between urban environment and the inflammatory bowel diseases: A systematic review and meta-Analysis. BMC Gastroenterol. 12:51. doi:10.1186/1471-230X-12-51.
152. Standaert-Vitse, A., Sendid, B., Joossens, M., Francois, N., Vandewalle-El Khoury, P., Branche, J., et al. (2009). Candida albicans Colonization and ASCA in familial Crohn's Disease. Am. J. Gastroenterol. 104, 1745-1753. doi:10.1038/ajg.2009.225.
153. Steck, N., Hoffmann, M., Sava, I., Kim, S., Hahne, H., Schemann, M., et al. (2011). Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Int. J. Med. Microbiol. 301, 106-106. doi:10.1053/j.gastro.2011.05.035.
154. Stepek, G., Auchie, M., Tate, R., Watson, K., Russell, D. G., Devaney, E., et al. (2002). Expression of the filarial nematode phosphorylcholine-containing glycoprotein, ES62, is stage specific. Parasitology 125, 155-164. doi:10.1017/S0031182002001920.
155. Strauss, J., Kaplan, G. G., Beck, P. L., Rioux, K., Panaccione, R., Devinney, R., et al. (2011). Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17, 1971-1978. doi:10.1002/ibd.21606.
156. Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R., and Weinstock, J. V. (2005a). Trichuris suis therapy in Crohn's disease. Gut 54, 87-90. doi:10.1136/gut.2004.041749.
157. Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R. A., and Weinstock, J. V. (2005b). Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology 128, 825-832. doi:10.1053/j.gastro.2005.01.005.
158. Tamboli, C. P., Neut, C., Desreumaux, P., and Colombel, J. F. (2004). Dysbiosis as a prerequisite for IBD. Gut 53, 1057. doi:10.1136/gut.53.1.1.
159. Turnbaugh, P. J., Baeckhed, F., Fulton, L., and Gordon, J. I. (2008). Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223. doi:10.1016/j.chom.2008.02.015.
160. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., et al. (2009). A core gut microbiome in obese and lean twins. Nature 457, 480-484. doi:10.1038/nature07540.
161. Turner, D., Levine, A., Kolho, K. L., Shaoul, R., and Ledder, O. (2014). Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report. J. Crohns Colitis 8, 1464-1470. doi:10.1016/j.crohns.2014.05.010.
162. Uhr, J. W., Dancis, J., Franklin, E. C., Finkelstein, M. S., and Lewis, E. W. (1962). The antibody response to bacteriophage phi-X 174 in newborn premature infants. J. Clin. Invest. 41, 1509-1513. doi:10.1172/JCI104606.
163. Underhill, D. M., and Iliev, I. D. (2014). The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14, 405-416. doi:10.1038/nri3684.
164. Varela, E., Manichanh, C., Gallart, M., Torrejón, A., Borruel, N., Casellas, F., et al. (2013). Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment. Pharmacol. Ther. 38, 151-161. doi:10.1111/apt.12365.
165. Velthuis, J. H., Unger, W. W., Abreu, J. R., Duinkerken, G., Franken, K., Peakman, M, et al. (2010). Simultaneous detection of circulating autoreactive CD8(+) T-cells specific for different islet cell-Associated epitopes using combinatorial MHC multimers. Diabetes 59, 1721-1730. doi:10.2337/db09-1486.
166. Virgin, H. W. (2014). The virome in mammalian physiology and disease. Cell 157, 142-150. doi:10.1016/j.cell.2014.02.032.
167. Vrieze, A., Van Nood, E., and Holleman, F. (2013). Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome (vol 143, pg 913, 2012). Gastroenterology 144, 250-250. doi:10.1053/j.gastro.2012.11.032.
168. Wagner, J., Maksimovic, J., Farries, G., Sim, W. H., Bishop, R. F., Cameron, D. J., et al. (2013). Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm. Bowel Dis. 19, 1598-1608. doi:10.1097/MIB.0b013e318292477c.
169. Waller, A. S., Yamada, T., Kristensen, D. M., Kultima, J. R., Sunagawa, S., Koonin, E. V., et al. (2014). Classification and quantification of bacteriophage taxa in human gut metagenomes. ISME J. 8, 1391-1402. doi:10.1038/ismej.2014.30.
170. Wehkamp, J., Harder, J., Wehkamp, K. B., Wehkamp-von Meissner, B., Schlee, M., Enders, C., et al. (2004). NF-κB-And AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: A novel effect of a probiotic bacterium. Infect. Immun. 72, 5750-5758. doi:10.1128/IAI.72.10.5750-5758.2004.
171. Weinstock, J. V., and Elliott, D. E. (2009). Helminths and the IBD hygiene hypothesis. Inflamm. Bowel Dis. 15, 128-133. doi:10.1002/ibd.20633.
172. Weinstock, J. V., Summers, R. W., Elliott, D. E., Qadir, K., Urban, J. F., and Thompson, R. (2002). The possible link between de-worming and the emergence of immunological disease. J. Lab. Clin. Med. 139, 334-338. doi:10.1067/mlc.2002.124343.
173. Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., et al. (2009). Twin studies reveal specific imbalances in the mucosa-Associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15, 653-660. doi:10.1002/ibd.20783.
174. Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y. Y., Keilbaugh, S. A., et al. (2011). Linking long-Term dietary patterns with gut microbial enterotypes. Science 334, 105-108. doi:10.1126/science.1208344.
175. Xenoulis, P. G., Palculict, B., Allenspach, K., Steiner, J. M., Van House, A. M., and Suchodolski, J. S. (2008). Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol. Ecol. 66, 579-589. doi:10.1111/j.1574-6941.2008.00556.x.
176. Yan, X., Sivignon, A., Yamakawa, N., Crepet, A., Travelet, C., Borsali, R., et al. (2015). Glycopolymers as antiadhesives of E. coli strains inducing inflammatory bowel diseases. Biomacromolecules 16, 1827-1836. doi:10.1021/acs.biomac.5b00413.
177. Yang, X. D., Yang, Y. P., Wang, Y. Y., Zhan, B., Gu, Y., Cheng, Y. L., et al. (2014)Excretory/secretory products from trichinella spiralis adult worms ameliorate DSS-induced colitis in mice. PLoS ONE 9:96454. doi:10.1371/journal.pone.0096454.
178. Yang, YJ., Kim, M.-S., Kim, E., Cheon, J. H., Lee, Y.-S., Choi, S. S., et al. (2016). Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-β production. Immunity 44, 889-900. doi:10.1016/j.immuni.2016.03.009.
179. Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., et al. (2012). Human gut microbiome viewed across age and geography. Nature 486, 222-227. doi:10.1038/nature11053.
180. Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., et al. (2017). Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548-563. 16. doi:10.1016/j.cell.2017.07.008.
181. Zhang, Y. F., and LeJeune, J. T. (2008). Transduction of bla(CMY-2), tet(A), and tet(B) from Salmonella enterica subspecies enterica serovar Heidelberg to S-Typhimurium. Vet. Microbiol. 129, 418-425. doi:10.1016/j.vetmic.2007.11.032.
182. Zhu, W. H., Winter, M. G., Byndloss, M. X., Spiga, L., Duerkop, B. A., Hughes, E. R., et al. (2018). Precision editing of the gut microbiota ameliorates colitis. Nature 553, 208-211. doi:10.1038/nature25172.
183. Zuo, T., Kamm, M. A., Colombel, J.-F., and Ng, S. C. (2018). Urbanization and the gut microbiota in health and inflammatory bowel disease. Nat. Rev. Gastro. Hepat. 15:440-452. doi:10.1038/s41575-018-0003-z.
184. Zuo, T., Wong, S. H., Lam, L. Y. K., Lui, R., Cheung, K., Tang, W., et al. (2017). Bacteriophage transfer during fecal microbiota transplantation is associated with treatment response in clostridium difficile infection. Gastroenterology 152, S140-S141. doi:10.1016/S0016-5085(17)30798-9.